RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
93.03%
This Fund
S&P 500
1 Year Est. Return
+93.03%
AUM
$1.7B
AUM Growth
-$252M
(-13%)
Holding
107
Top Buys
| 1 | +$17.4M | |
| 2 | +$15M | |
| 3 | +$9.3M | |
| 4 |
HTFL
Heartflow Inc
HTFL
|
+$8M |
| 5 |
PTC Therapeutics
PTCT
|
+$7.08M |
Top Sells
| 1 | +$61.1M | |
| 2 | +$45.3M | |
| 3 | +$27.4M | |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$24M |
| 5 |
Travere Therapeutics
TVTX
|
+$21.9M |
Sector Composition
| 1 | Healthcare | 99.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
101
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-204,878
|
|
||
|
EXAS
102
DELISTED
Exact Sciences
EXAS
| – | – |
-601,800
|
|
||
|
MRSN
103
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-152,586
|
|
||
|
NUVB.WS
104
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| – | – |
-134,028
|
|
||
|
RAPT
105
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-213,731
|
|
||
106
Theravance Biopharma
TBPH
$828M
| – | – |
-208,771
|
|